Viyash Scientific Ltd reports Q2 FY27 revenue of ₹9,879 million, up 16.2% year on year
- EBITDA before ESOP costs was ₹2,077 million, with a 21.0% margin, up 10.3% year on year.
- PAT was ₹847 million, up 16.1% year on year; adjusted PAT was ₹1,110 million.
- Revenue rose 4.4% sequentially, while EBITDA before ESOP costs increased 1.5%.
